Articles

Pembrolizumab (Keytruda) plus fluoropyrimidine- and platinum-containing chemotherapy for locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction cancer approved by FDA after being found to lower the risk of metastasis or death.

FDA Approves Merck's Keytruda With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma

ClearNetwork will be available for a plan sponsor’s list of covered generic, branded, and specialty drugs across 65,000 retail pharmacies in the Express Scripts network.

Major PBM to Offer Cost-Based Pricing Option for Prescription Medications 

Bristol Myers Squibb’s repotrectinib (Augtyro) approved by FDA to treat locally advanced or metastatic ROS1-positive non-small cell lung cancer.

FDA Approves New Treatment for ROS1-Positive Non-Small Cell Lung Cancer 

Patients with kidney failure administered chronic hemodialysis who received DefenCath showed a statistically significant lower incidence of catheter-related bloodstream infections.

FDA Approves Defencath to Treat Catheter-Related Bloodstream Infections 

Findings suggest that participants nationwide who were offered and accessed their online medical record has more than doubled in the past eight years, but racial and ethnic disparities continue. 

Study Digs into Patient Access to Electronic Health Information

Parties will provide processing and packaging machinery services.

MG America, Romaco North America Launch North American Alliance 

Study estimates that up to 20% of the costs for clinical research is associated with the manual transfer and verification of data from the electronic medical record to a data capture system.

AI Can Save Pharma Time and Money, But Concerns Persist With Data Security

New initiative highlights importance of a collaborative approach that allows patients to share their insights and contribute value to studies.

Project Highlights Benefits of Statistical Methodology Research for Patients, Pharma

Stem Cell Reports takes a look at DTC online advertising claims that these are ‘immune boosters.’

 Open Access Forum Analyzes COVID-19 Stem Cell and Exosome Therapies

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.

News